APSARD January 1 - 2025 Supporting materials POSTER: Impact of Centanafadine on Executive Functioning in Pediatric Patients With Attention-Deficit/Hyperactivity Disorder: Analysis of Conners 3 and Exit Survey Responses POSTER: Impact of Intrinsic Factors on the Efficacy of Centanafadine in an Adult Population with Attention- Deficit/Hyperactivity Disorder POSTER: Efficacy of Centanafadine for the Treatment of Adults with Severe Combined Presentation of Attention-Deficit/ Hyperactivity Disorder POSTER: Effect of Centanafadine on the AIM-A After 6 Weeks of Treatment in Adults with ADHD: A Pooled Analysis of Two Phase 3 Trials POSTER: A Post hoc Analysis Evaluating the Baseline Characteristics That Facilitate Early Identification of Those who are Likely to Respond to Centanafadine at Week 6 POSTER: Centanafadine Treatment Response in a Pediatric Population With Attention-Deficit/Hyperactivity Disorder POSTER: Efficacy of Centanafadine on Conners 3 Content Scales in Adolescents With Attention-Deficit/Hyperactivity Disorder Population POSTER: Comparison of Caregiver Exit Survey With Efficacy Measures in the Treatment of Attention-Deficit/Hyperactivity Disorder With Centanafadine in a Pediatric Population POSTER: Efficacy of Centanafadine on Conners 3 Content Scales in Children With Attention-Deficit/Hyperactivity Disorder POSTER: Ward CL, van Stralen J, Jin N, et al. Presented at: American Professional Society of ADHD and Related Disorders (ASPARD) Meeting, January 16-19, 2025; San Diego, CA, USA.
